Stem
STEM
NYSE
IPO2021
about STEM
Stem specializes in developing cutting-edge stem cell-based therapies and innovative solutions aimed at advancing medical treatments in regenerative medicine.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $17.78 | $19.75 | $17.77 | $164.53M | 545.17K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.84 | n/a | 4.38 | -33.61% | -62.22% | 0% |
